{"transactions":[{"id":2729330,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":139741,"kind":"person","name":"UPMC","position":1,"cik":"0001644244","reported_name":"UPMC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-05-04T16:30:22.000Z","date":"2021-05-04","kind":"exercise","acquired":false,"shares":2373701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":273811},"source":{"system":"sec-edgar","filing":"0000899243-21-018109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1644244/000089924321018109/doc4.xml","form_type":"4"}},{"id":2729329,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":139741,"kind":"person","name":"UPMC","position":1,"cik":"0001644244","reported_name":"UPMC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-05-04T16:30:22.000Z","date":"2021-05-04","kind":"exercise","acquired":false,"shares":7142857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 4, 2021, the Series A Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 4, 2021, the Series A Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 4, 2021, the Series A Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":823945},"source":{"system":"sec-edgar","filing":"0000899243-21-018109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1644244/000089924321018109/doc4.xml","form_type":"4"}},{"id":2729328,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":139741,"kind":"person","name":"UPMC","position":1,"cik":"0001644244","reported_name":"UPMC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T16:30:22.000Z","date":"2021-05-04","kind":"exercise","acquired":true,"shares":273811,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":1097756,"source":{"system":"sec-edgar","filing":"0000899243-21-018109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644244/000089924321018109/doc4.xml","form_type":"4"}},{"id":2729327,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":139741,"kind":"person","name":"UPMC","position":1,"cik":"0001644244","reported_name":"UPMC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T16:30:22.000Z","date":"2021-05-04","kind":"exercise","acquired":true,"shares":823945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 4, 2021, the Series A Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":823945,"source":{"system":"sec-edgar","filing":"0000899243-21-018109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644244/000089924321018109/doc4.xml","form_type":"4"}},{"id":4309534,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":139741,"kind":"person","name":"UPMC","position":1,"cik":"0001644244","reported_name":"UPMC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $.01 per share","published_at":"2017-05-22T18:01:57.000Z","date":"2017-05-19","kind":"sale","acquired":false,"shares":2333333,"price":24.3,"value":56699991.9,"ownership":{"direct":true},"balance_after":6434283,"source":{"system":"sec-edgar","filing":"0001644244-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164424417000003/primary_doc.xml","form_type":"4"}},{"id":4334556,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":139741,"kind":"person","name":"UPMC","position":1,"cik":"0001644244","reported_name":"UPMC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $.01 per share","published_at":"2017-05-03T18:17:53.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":403644,"price":19.53,"value":7883167.32,"ownership":{"direct":true},"balance_after":8767616,"source":{"system":"sec-edgar","filing":"0001644244-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164424417000002/primary_doc.xml","form_type":"4"}},{"id":4366461,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":139741,"kind":"person","name":"UPMC","position":1,"cik":"0001644244","reported_name":"UPMC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $.01 per share","published_at":"2017-03-31T21:17:19.000Z","date":"2017-03-31","kind":"sale","acquired":false,"shares":2690961,"price":19.53,"value":52554468.33,"ownership":{"direct":true},"balance_after":9171260,"source":{"system":"sec-edgar","filing":"0001644244-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164424417000001/primary_doc.xml","form_type":"4"}},{"id":4595844,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":139741,"kind":"person","name":"UPMC","position":1,"cik":"0001644244","reported_name":"UPMC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $.01 per share","published_at":"2016-09-23T20:11:22.000Z","date":"2016-09-22","kind":"sale","acquired":false,"shares":403644,"price":21.54,"value":8694491.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $21.54 represents the public offering price of $22.50 per share of Class A Common Stock less the underwriters' discount of $0.96 per share."}],"balance_after":11862221,"source":{"system":"sec-edgar","filing":"0001644244-16-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164424416000003/primary_doc.xml","form_type":"4"}},{"id":4601165,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":139741,"kind":"person","name":"UPMC","position":1,"cik":"0001644244","reported_name":"UPMC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $.01 per share","published_at":"2016-09-16T16:42:43.000Z","date":"2016-09-14","kind":"sale","acquired":false,"shares":2460307,"price":21.54,"value":52995012.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $21.54 represents the public offering price of $22.50 per share of Class A Common Stock less the underwriters' discount of $0.96 per share."}],"balance_after":12265865,"source":{"system":"sec-edgar","filing":"0001644244-16-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000164424416000002/primary_doc.xml","form_type":"4"}}]}